Physician

Vlada W Mardovin, M.D.

According to 2025 Medicare claims, Vlada Mardovin, M.D. (NPI: 1437224508) practices urology in the Springfield, OH market, with the plurality of this provider's patient population coming from Clark, OH. This provider's primary affiliated billing organization is SPRINGFIELD UROLOGY LLC (NPI: 1992922025; TIN: 208629620) and primary practice location at 45503-2726. Mardovin is affiliated with the Mercy Health Select, LLC (ACO ID: A1215), participating under the MSSP model.

Mardovin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 581 traditional Medicare patients, billed 3,769 HCPCS/CPT codes, and received $407,745 in Medicare payments. The top billing code was 52000 (Diagnostic exam of bladder and urethra using an endoscope). Part D data shows 2,595 prescription claims across 693 beneficiaries totaling $293,818 in drug costs, led by Orgovyx (Relugolix). DME data shows 90 claims. Open Payments data shows 33 records totaling $1,567. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $180,203 and ending at $407,745. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and declined steadily, from $1,192 to $410.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	675	3,227	$180,203
2016	832	4,801	$221,969
2017	832	4,615	$248,326
2018	788	5,196	$254,114
2019	684	4,675	$292,869
2020	635	4,684	$241,564
2021	647	8,449	$354,002
2022	556	6,193	$287,662
2023	553	3,672	$168,836
2024	581	3,769	$407,745

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	722	3,295	$202,541
2016	727	3,366	$203,013
2017	738	3,139	$206,626
2018	745	3,244	$212,461
2019	701	2,603	$147,408
2020	670	2,461	$125,977
2021	654	2,390	$116,266
2022	635	2,324	$131,410
2023	646	2,248	$248,553
2024	693	2,595	$293,818

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	11	119	$14,662
2016	26	132	$18,788
2017	31	225	$21,152
2018	30	265	$31,129
2019	14	272	$39,790
2020	11	255	$31,382
2021	12	196	$25,565
2022	N/R	115	$10,379
2023	N/R	75	$7,557
2024	N/R	90	$10,986

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
52000	Diagnostic exam of bladder and urethra using an endoscope	77	86	$148
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	173	245	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	353	607	$59
51798	Ultrasound measurement of bladder capacity after voiding	162	230	$7
81002	Urinalysis, manual test	342	577	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orgovyx	Relugolix	23	856	$78,971
Gemtesa	Vibegron	55	2,873	$44,912
Myrbetriq	Mirabegron	61	2,913	$43,604
Solifenacin Succinate	Solifenacin Succinate	192	7,225	$9,778
Silodosin	Silodosin	165	7,050	$8,307

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	61	$10,728
A4332	Lubricant, individual sterile packet, each	N	N/R	29	$258

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	33	$1,567	Dendreon Pharmaceuticals LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vlada W. Mardovin, M.D.?

Tedicare shows public-source Medicare data for Vlada W. Mardovin, M.D. (NPI 1437224508), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vlada W. Mardovin, M.D. have ACO affiliation data?

Vlada W. Mardovin, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215).

What billing organization is linked to Vlada W. Mardovin, M.D.?

Vlada W. Mardovin, M.D. is linked to SPRINGFIELD UROLOGY LLC (billing NPI 1992922025) in the available physician profile data.

Does Vlada W. Mardovin, M.D. have Open Payments data?

Vlada W. Mardovin, M.D. has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.